The announcement of pre-orders for a new EV product directly impacts Medigus as it represents a new revenue stream and a strategic move into a growing market. This news is likely to be viewed positively by investors, as it indicates expansion and innovation. However, the actual impact on the stock will depend on the market's perception of the company's ability to deliver on its promises and the public's interest in the new EV.